Literature DB >> 19542610

Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.

Xin-Wen Zhou1, Bengt Winblad, Zhizhong Guan, Jin-Jing Pei.   

Abstract

In this study, we investigated how tau phosphorylation is regulated by protein kinase glycogen synthase kinase 3beta (GSK3 beta), protein kinase B (PKB), and protein phosphatase 2A (PP2A) in mouse N2a neuroblastoma cells. Results showed that GSK3 beta overexpression significantly increased PKB phosphorylation at the S473 site but not the T308 site. Neither GSK3 beta nor PKB overexpression could reduce the PP2AC phosphorylation at the Y307 site. In contrast, either PKB or GSK3 beta knockdown could increase PP2A phosphorylation at the Y307 site. PP2AC knockdown increased GSK3 beta phosphorylation at the S9 site but not at the Y216 site, and PKB phosphorylation at the T308 site but not at the S473 site. Tau phosphorylation at the S396 site was increased by GSK3 beta or PKB overexpression. Tau phosphorylation at the S214 site was only induced by PKB overexpression in the study. While GSK3 beta knockdown decreased tau phosphorylation at the S396 site, PKB knockdown increased tau phosphorylation at both the S396 and S214 sites. PP2AC knockdown decreased tau phosphorylation at the S396 and S214 sites. These findings suggest that tau phosphorylation at the S396 and S214 sites is differentially regulated by GSK3 beta, PKB, and PP2A in N2a cells. The final phosphorylation state of tau is possibly caused by the synergic action of the three enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542610     DOI: 10.3233/JAD-2009-1113

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

1.  Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.

Authors:  Sasuk Kim; Juhee Lim; Yeojin Bang; Jisook Moon; Min-Soo Kwon; Jin Tae Hong; Jeha Jeon; Hyemyung Seo; Hyun Jin Choi
Journal:  Mol Neurobiol       Date:  2017-02-11       Impact factor: 5.590

2.  Tumor necrosis factor-α induces increased lung vascular permeability: a role for GSK3α/β.

Authors:  Amy Barton-Pai; Carlos Feleder; Arnold Johnson
Journal:  Eur J Pharmacol       Date:  2011-02-12       Impact factor: 4.432

3.  Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons.

Authors:  Antonio Currais; Kiyoko Kato; Leonides Canuet; Ryouhei Ishii; Toshihisa Tanaka; Masatoshi Takeda; Salvador Soriano
Journal:  J Mol Neurosci       Date:  2010-09-14       Impact factor: 3.444

Review 4.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

Review 5.  The role of tau in Alzheimer's disease and related disorders.

Authors:  Rodrigo Medeiros; David Baglietto-Vargas; Frank M LaFerla
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

6.  Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.

Authors:  Weili Sun; Shakeel Modak
Journal:  Onco Targets Ther       Date:  2012-03-02       Impact factor: 4.147

7.  Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.

Authors:  Otto Kauko; Teemu Daniel Laajala; Mikael Jumppanen; Petteri Hintsanen; Veronika Suni; Pekka Haapaniemi; Garry Corthals; Tero Aittokallio; Jukka Westermarck; Susumu Y Imanishi
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

8.  Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone.

Authors:  Rodolfo Pinto-Almazan; Julia J Segura-Uribe; Marvin A Soriano-Ursúa; Eunice D Farfán-García; Juan M Gallardo; Christian Guerra-Araiza
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

9.  Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.

Authors:  Madhumathi Gnanaprakash; Agnieszka Staniszewski; Hong Zhang; Rose Pitstick; Michael P Kavanaugh; Ottavio Arancio; Russell E Nicholls
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.

Authors:  Roger J Mullins; Thomas C Diehl; Chee W Chia; Dimitrios Kapogiannis
Journal:  Front Aging Neurosci       Date:  2017-05-03       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.